Dermazor

Product NDC
63302-202
Requested package NDC
63302-202-01
11-digit product format
633020202
Labeler code
63302
Product ID
63302-202_2a846da9-2949-418e-b0c4-0eb2f0a58301
Type
HUMAN OTC DRUG
Nonproprietary name
Salicylic Acid, Zinc Oxide
Dosage form
CREAM
Route
TOPICAL
Labeler
PRESTIGIO LTD
Application
part358H
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2014-05-05
Marketing end
0000-00-00
Substance
SALICYLIC ACID
Active strength
3 g/100g
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage63302-20263302-202-01IInactivated by FDA2026-10-20

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-288af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-081332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29fb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-0886f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01bd6a592717d7…303034d00443…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63302-202-012022-01-28C16284748780-1d6a99b39-5168-a426-e053-dadaa90af4c2Drug Facts
63302-202-022022-01-28C16284748780-1d6a99b39-5168-a426-e053-dadaa90af4c2Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63302-202-01DermazorPsoriasis and Seborrheic Dermatitis100 g in 1 TUBECREAM1005
63302-202-02DermazorPsoriasis and Seborrheic Dermatitis100 g in 1 TUBECREAM1005

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SALICYLIC ACIDACTIVE INGREDIENTO414PZ4LPZDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
.ALPHA.-TOCOPHEROLINACTIVE INGREDIENTH4N855PNZ1DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
ALMOND OILINACTIVE INGREDIENT66YXD4DKO9DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
BORAGE OILINACTIVE INGREDIENTF8XAG1755SDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
CALENDULA OFFICINALIS FLOWERINACTIVE INGREDIENTP0M7O4Y7YDDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
CHIA SEED OILINACTIVE INGREDIENTMC2LH51BO7DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
EVENING PRIMROSE OILINACTIVE INGREDIENT3Q9L08K71NDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
GRAPE SEED OILINACTIVE INGREDIENT930MLC8XGGDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
LANOLININACTIVE INGREDIENT7EV65EAW6HDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
LAVENDER OILINACTIVE INGREDIENTZBP1YXW0H8DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
LEVOMENOLINACTIVE INGREDIENT24WE03BX2TDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
NIGELLA SATIVA SEED OILINACTIVE INGREDIENTCS4U38E731DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
PETROLATUMINACTIVE INGREDIENT4T6H12BN9UDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3TDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
SILYBUM MARIANUM SEED OILINACTIVE INGREDIENTNYY23HEN06DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
VITAMIN AINACTIVE INGREDIENT81G40H8B0TDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
WATERINACTIVE INGREDIENT059QF0KO0RDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
WHITE WAXINACTIVE INGREDIENT7G1J5DA97FDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1
ZINC OXIDEINACTIVE INGREDIENTSOI2LOH54ZDERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63302-202DERMAZOR PSORIASIS AND SEBORRHEIC DERMATITIS (SALICYLIC ACID, ZINC OXIDE) CREAM [PRESTIGIO LTD]5Legacy NDC, 2 package rows20200117_df95a616-714e-4727-af91-1b993a55b661.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1537091Dermazor 3 % Topical CreamPSNdf95a616-714e-4727-af91-1b993a55b6615
416910salicylic acid 3 % Topical CreamPSNdf95a616-714e-4727-af91-1b993a55b6615
1537091salicylic acid 30 MG/ML Topical Cream [Dermazor]SBDdf95a616-714e-4727-af91-1b993a55b6615
416910salicylic acid 30 MG/ML Topical CreamSCDdf95a616-714e-4727-af91-1b993a55b6615
1537091Dermazor 3 % Topical CreamSYdf95a616-714e-4727-af91-1b993a55b6615
1537091Dermazor 30 MG/ML Topical CreamSYdf95a616-714e-4727-af91-1b993a55b6615
416910salicylic acid 3 % Topical CreamSYdf95a616-714e-4727-af91-1b993a55b6615

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63302-202-0163302020201100 g in 1 TUBE (63302-202-01) 100 g2014-05-050000-00-00NoNoCurrent